Klaus Christensen, CCO

Ph.D Bioorganic chemistry, University of Copenhagen and M.Sc. in Chemical Engineering with over 25 years of experience as VP R&D BioNebraska Inc., VP Nordic Bioscience A / S, COO Verigen Europe A / S, VP Osteometer Biotech, MD BION and CEO Sanos Biosciences. Has provided commercial leadership spanning from early R&D to launched brands for several biotechs, AstraZeneca and LEO Pharma.